FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

9298911000001100: Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
30633701000001117 Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
39447601000001116 Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet Is a Moxonidine 200microgram tablets 28 tablet true Inferred relationship Existential restriction modifier
Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet Is pack of Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) false Inferred relationship Existential restriction modifier
Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet Has active ingredient Moxonidine false Inferred relationship Existential restriction modifier
Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet Has AMP Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) true Inferred relationship Existential restriction modifier
Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet Has specific active ingredient Moxonidine true Inferred relationship Existential restriction modifier
Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Moxonidine 200microgram tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start